Medacta Group SA MOVE
SIX · Switzerland · Health Technology
CHF 113.00-0.60 (-0.53%)
Market open· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Medacta Group SA (MEDGF) posts nearly 10% constant-currency revenue growth in H1 2026 while navigating FX headwinds, US market softness, and Spanish strikes.
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Medacta Group SA (XSWX:MOVE) reports strong financial performance with significant revenue growth and strategic expansion plans despite market challenges.
While Medacta Group SA ( VTX:MOVE ) might not have the largest market cap around , it saw significant share price...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.